Search research articles
Contact Us
Filters
Showing results (21-30 of 109) with videos related to
Page
of 11
Sort By:
Contraception
|
June 26, 2007
Further results on the risk of nonfatal venous thromboembolism in users of the contraceptive transdermal patch compared to users of oral contraceptives containing norgestimate and 35 microg of ethinyl estradiol
Susan Jick, James A Kaye, Lin Li, et al.
Pharmacotherapy
|
September 27, 2006
Nonsteroidal antiinflammatory drugs and acute myocardial infarction in patients with no major risk factors
Hershel Jick, James A Kaye, Stefan Russmann, et al.
Clinical Breast Cancer
|
December 5, 2017
Treatment Patterns and Outcomes of Patients With Metastatic ER<sup>+</sup>/HER-2<sup>-</sup> Breast Cancer: A Multicountry Retrospective Medical Record Review
Samantha K Kurosky, Debanjali Mitra, Giovanni Zanotti, et al.
Journal of Health Economics and Outcomes Research
|
September 4, 2023
Real-World Treatment Patterns in Men with Castration- Resistant Prostate Cancer Receiving Docetaxel
Keith L Davis, Benjamin Gutierrez, Teresa Zyczynski, et al.
Contraception
|
May 30, 2006
Risk of nonfatal venous thromboembolism with oral contraceptives containing norgestimate or desogestrel compared with oral contraceptives containing levonorgestrel
Susan S Jick, James A Kaye, Stefan Russmann, et al.
Current Medical Research and Opinion
|
November 27, 2014
Treatment patterns and prognostic indicators of response to therapy among patients with chronic myeloid leukemia in Australia, Canada, and South Korea
Jennifer Whiteley, Shrividya Iyer, Sean D Candrilli, et al.
British Journal of Clinical Pharmacology
|
June 21, 2005
Risk of cholestatic liver disease associated with flucloxacillin and flucloxacillin prescribing habits in the UK: cohort study using data from the UK General Practice Research Database
Stefan Russmann, James A Kaye, Susan S Jick, et al.
Contraception
|
February 14, 2006
Risk of nonfatal venous thromboembolism in women using a contraceptive transdermal patch and oral contraceptives containing norgestimate and 35 microg of ethinyl estradiol
Susan S Jick, James A Kaye, Stefan Russmann, et al.
Applied Health Economics and Health Policy
|
May 17, 2013
Medicare fee-for-service enrollees with primary acute myeloid leukemia: an analysis of treatment patterns, survival, and healthcare resource utilization and costs
Juliana Meyers, Yanni Yu, James A Kaye, et al.
Contraception
|
July 28, 2009
The risk of unintended pregnancies in users of the contraceptive patch compared to users of oral contraceptives in the UK General Practice Research Database
Susan S Jick, Katrina W Hagberg, James A Kaye, et al.
Page
of 11
Search research articles
Search
Showing results (21-30 of 109) with videos related to
Sort By:
Page
of 11
Contraception
|
June 26, 2007
Further results on the risk of nonfatal venous thromboembolism in users of the contraceptive transdermal patch compared to users of oral contraceptives containing norgestimate and 35 microg of ethinyl estradiol
Susan Jick, James A Kaye, Lin Li, et al.
Pharmacotherapy
|
September 27, 2006
Nonsteroidal antiinflammatory drugs and acute myocardial infarction in patients with no major risk factors
Hershel Jick, James A Kaye, Stefan Russmann, et al.
Clinical Breast Cancer
|
December 5, 2017
Treatment Patterns and Outcomes of Patients With Metastatic ER<sup>+</sup>/HER-2<sup>-</sup> Breast Cancer: A Multicountry Retrospective Medical Record Review
Samantha K Kurosky, Debanjali Mitra, Giovanni Zanotti, et al.
Journal of Health Economics and Outcomes Research
|
September 4, 2023
Real-World Treatment Patterns in Men with Castration- Resistant Prostate Cancer Receiving Docetaxel
Keith L Davis, Benjamin Gutierrez, Teresa Zyczynski, et al.
Contraception
|
May 30, 2006
Risk of nonfatal venous thromboembolism with oral contraceptives containing norgestimate or desogestrel compared with oral contraceptives containing levonorgestrel
Susan S Jick, James A Kaye, Stefan Russmann, et al.
Current Medical Research and Opinion
|
November 27, 2014
Treatment patterns and prognostic indicators of response to therapy among patients with chronic myeloid leukemia in Australia, Canada, and South Korea
Jennifer Whiteley, Shrividya Iyer, Sean D Candrilli, et al.
British Journal of Clinical Pharmacology
|
June 21, 2005
Risk of cholestatic liver disease associated with flucloxacillin and flucloxacillin prescribing habits in the UK: cohort study using data from the UK General Practice Research Database
Stefan Russmann, James A Kaye, Susan S Jick, et al.
Contraception
|
February 14, 2006
Risk of nonfatal venous thromboembolism in women using a contraceptive transdermal patch and oral contraceptives containing norgestimate and 35 microg of ethinyl estradiol
Susan S Jick, James A Kaye, Stefan Russmann, et al.
Applied Health Economics and Health Policy
|
May 17, 2013
Medicare fee-for-service enrollees with primary acute myeloid leukemia: an analysis of treatment patterns, survival, and healthcare resource utilization and costs
Juliana Meyers, Yanni Yu, James A Kaye, et al.
Contraception
|
July 28, 2009
The risk of unintended pregnancies in users of the contraceptive patch compared to users of oral contraceptives in the UK General Practice Research Database
Susan S Jick, Katrina W Hagberg, James A Kaye, et al.
Page
of 11